INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

RCELAVITA Medical, Inc.

CIK 0001762303

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score32
Connections3with evidence

RCEL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
CS
Crowe SuzanneDirector
RCELAVITA Medical, Inc.
Grant or award
A—
22.2K sh
Jan 20, 2026Jun 4, 2026
traded Jan 20, 2026
+135dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA 1T 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • ← Insider ofevidence
    Crowe SuzanneDirector · Jun 4, 2026
24
CS
Crowe SuzanneDirector
RCELAVITA Medical, Inc.
Grant or award
A
—
16.1K sh
Jan 20, 2026
Jun 4, 2026
traded Jan 20, 2026
+135d
SEC FORM 4

Evidence

Lobbying

$15K reported · de-duplicated
2026 Q1 $15K via firms
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.$15K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.